Viewing Study NCT02860559


Ignite Creation Date: 2025-12-24 @ 3:01 PM
Ignite Modification Date: 2026-02-20 @ 3:51 PM
Study NCT ID: NCT02860559
Status: UNKNOWN
Last Update Posted: 2020-10-08
First Post: 2016-07-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Early Efficacy Study of TBX-1400 in Patients With Severe Combined Immunodeficiency
Sponsor: Taiga Biotechnologies, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Severe Combined Immunodeficiency View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hematopoietic Stem Cell Transplantation View
None Severe Combined Immunodeficiency View